Core Cap Advisors, LLC Charles River Laboratories International, Inc. Transaction History
Core Cap Advisors, LLC
- $2.64 Billion
- Q3 2025
A detailed history of Core Cap Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 29 shares of CRL stock, worth $5,157. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29
Previous 29
-0.0%
Holding current value
$5,157
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CRL
# of Institutions
640Shares Held
52.9MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.03 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$905 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$670 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$387 Million0.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$331 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.05B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...